EpidStat Institute provides scientific expertise related to health issues, pharmaceuticals, medical devices, and environmental chemicals. Our target clientele include companies and groups needing expert assistance, evaluation of complex health issues, and assistance with the conduct and interpretation of epidemiological studies.
Apologies, but no entries were found.
EpidStat in the News
EconStat made several presentations at the recent ISPOR 2018 Congress. “Vascular Access-Specific HRQOL Impacts Among Hemodialysis Patients: The Hemodialysis Access-Related QOL (HARQ) Project Focus Group Results Results” highlighted results from qualitative research to develop a novel quality of life questionnaire for dialysis patients. Two presentations focused on economic analyses of a novel vasopressor used in the intensive care unit; the cost-effectiveness analysis showed Giapreza to be a highly cost-effective treatment for severe distributive shock in the ICU.